New PET probe aims to spot kidney cancer earlier and more accurately
NCT ID NCT07590310
First seen May 16, 2026 · Last updated May 16, 2026
Summary
This early-phase study is testing a new imaging probe that targets a protein called CAIX, which is found in high levels in most clear cell kidney cancers. The goal is to see if this probe can help detect these tumors more accurately and non-invasively using PET scans. The study involves 3 participants with kidney cancer and focuses on safety and how well the probe works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY CANCERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Peking University Cancer Hospital
RECRUITINGBeijing, Haidian, 10000, China
Conditions
Explore the condition pages connected to this study.